Skip to content
Search

Latest Stories

Professor Colin Melville to retire from GMC next summer

Professor Colin Melville to retire from GMC next summer

The GMC will start the recruitment process for his successor in September this year

Professor Colin Melville has announced his plan to retire as the Medical Director and Director of Education and Standards at the General Medical Council (GMC) next summer.

Professor Melville joined the GMC in 2017, transitioning from his role as head of Lancaster Medical School.


Before that, he held senior leadership roles at Warwick Medical School, Hull York Medical School, and North Yorkshire East Coast Foundation School.

Professor Melville said: “It has been a difficult decision to leave the GMC, which is a fantastic organisation with so many wonderful colleagues.

“I have had the privilege of overseeing some exciting changes to education and standards, but I believe now is the right for me to step back from a full-time executive role.

“And, of course, I am looking forward to doing some different things and having more time for family and friends.”

A registered doctor and former consultant in intensive care medicine, Professor Melville began his clinical career in 1983.

He was awarded Honorary Fellow of the Academy of Medical Educators in 2018 and became an Honorary Professor in Medical Education at Manchester University. In 2022, he was also appointed Visiting Professor at Anglia Ruskin University.

Professor Melville will retire at the end of June 2025 and the recruitment process for his successor will commence in September, with the position being advertised across the UK through an open campaign.

During his time at the GMC, Professor Melville has overseen the introduction of the Medical Licensing Assessment. He has been instrumental in the regulator’s work to address unfairness in undergraduate and postgraduate medical education, and played a key role in ensuring education and training was maintained during the pandemic.

Charlie Massey, Chief Executive and Registrar of the GMC, said: “While at the GMC Colin has provided strong leadership and strategic direction, and worked tirelessly to oversee an ambitious programme of work that has contributed to real change for the benefit of patients and doctors.

“We are hugely grateful for all that he has achieved, and will be sorry to see him leave.”

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less